Psychosocial and behavioral support for stem cell transplant patients and their family caregivers
Adapting After Discharge From Allogeneic SCT: Partnering Together; Dyadic Intervention to Improve Patient-Family Caregiver Team-Based Management of the Medical Regimen After Allogeneic Hematopoietic Cell Transplantation
This project tests two brief four-session video counseling programs to help stem cell transplant patients and their family caregivers manage care and stick to medical instructions after hospital discharge.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 208 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Trial ID | NCT07107165 on ClinicalTrials.gov |
What this trial studies
This is a randomized controlled trial enrolling patient–caregiver dyads after hematopoietic stem cell transplant to compare a skills-learning intervention versus a supportive-care intervention. Each intervention includes four live videoconference sessions delivered to the dyad, with 52 dyads randomized to each arm. Patients and caregivers complete questionnaires at baseline and at 1, 5, 12, and 24 weeks to track adherence, perceived task efficacy, and psychosocial outcomes. The trial focuses on short, scalable psychosocial support to improve post-discharge self-management.
Who should consider this trial
Good fit: Ideal candidates are adults receiving a stem cell transplant at the University of Pittsburgh Hillman Cancer Center who have an adult family caregiver willing to participate, are English-speaking, have not had a prior transplant, and accept randomization.
Not a fit: Patients without an available family caregiver, non-English speakers, those with a prior stem cell transplant, those unwilling to be randomized, or those lacking access to videoconferencing are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the interventions could improve patient adherence to the transplant care regimen, reduce caregiver strain, and improve short-term psychosocial and health-related outcomes.
How similar studies have performed: Related psychosocial and problem-solving interventions in oncology and transplant settings have shown promising effects on adherence and caregiver outcomes, but brief four-session dyadic programs delivered by videoconference are less well studied.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient undergoing a stem cell transplant at the University of Pittsburgh Hillman Cancer Center * 18 years or older * having a family caregiver age 18 years or older also willing to participate in the study * willing to accept randomization Exclusion Criteria: * Prior history of stem cell transplant * Non-English speaking
Where this trial is running
Pittsburgh, Pennsylvania
- University of Pittsburgh Medical Center Hillman Cancer Center — Pittsburgh, Pennsylvania, United States (Recruiting)
Study contacts
- Study coordinator: Donna Posluszny, PhD
- Email: poslusznydm@upmc.edu
- Phone: 412-623-5966
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.